Work

Emerging phase 1 data of BLU-451 in advanced NSCLC with EGFR exon 20 insertions.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.9064

Authors: Danny Nguyen, Elaine Shum, Christina S Baik, Pasi A. Janne, Jyoti D. Patel, Erin Lynn Schenk, Yuji Shibata, Helena Alexandra Yu, Faris Albayya, Paul Pearson, Minjie Feng, Melinda Louie-Gao, Alena Zalutskaya, Alexander I. Spira

Institutions: City of Hope, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, Northwestern Memorial Hospital, Northwestern Medicine, University of Colorado Anschutz, National Cancer Center Hospital East, Memorial Sloan Kettering Cancer Center, Blueprint Medicines (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379281137

Cites:

Cited by: 9

Related to: 10